StockWatch
·

Himadri Speciality Chemical Ltd

BSE: 500184

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
1.6K
+19.1%+43.1%
Expenditure
1.3K
+22.2%+47.3%
Net Profit
239.77
+7.3%+28.3%
OPM %
20.73%
-0.94pp-1.47pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00444.36888.721.3K1.8KQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Himadri Q2 FY27: Consolidated PAT +31% YoY to ₹231 Cr, Margins Slip on 58% Revenue Jump

speciality chemicals · carbon black · margin compression

ResultsQ2 FY2716 Oct 20263 minMetals & Mining

Tougher Comps, New Capacity Online—Growth Still On Track

specialty chemicals · anthraquinone · carbazole

Result previewQ2 FY2711 Oct 20263 minMetals & Mining

Himadri to absorb Dalmia Bharat Refractories' tyre business; new shares add just 0.035% to its equity

demerger · scheme of arrangement · tyre business

Research21 Sept 20264 minMetals & Mining
Latest
Quarterly Result16 Oct, 6:30 pm

Himadri Q2 FY27: Consolidated PAT +31% YoY to ₹231 Cr, Margins Slip on 58% Revenue Jump

Himadri Speciality Chemical's consolidated PAT rose 31.3% YoY to ₹231.32 Cr (EPS ₹4.60 vs ₹3.58) on revenue of ₹1,691.43 Cr, up 57.9% YoY and 18.1% QoQ from ₹1,431.88 Cr in Q1 FY27. Against our pre-result preview (consolidated revenue ₹1,350–1,400 Cr, PAT ₹210–230 Cr), the top line beat by roughly 21% above the high end while PAT landed just above the top of the range — a clear revenue beat that only partially converted to the bottom line. The gap is a margin story: operating margin (per the filing's own ratio, PBT + depreciation + finance costs − other income, over revenue) came in at 17.93%, down from 22.21% in the year-ago quarter and 21.87% last quarter; net profit margin fell to 13.68% from 16.45% YoY and 15.95% QoQ. In absolute terms that operating-profit measure works out to roughly ₹303 Cr — squarely inside the preview's ₹300–310 Cr EBITDA-band despite revenue running ~21% ahead of what the preview assumed, meaning the incremental revenue carried materially lower margin than the base business. Finance costs held flat YoY (₹27.72 Cr) and the tax rate was unremarkable (24.7% of PBT), so the squeeze sits upstream, in cost of materials and other expenses, consistent with a richer mix from newly consolidated, lower-margin units. Standalone (parent-only) tells a milder version: revenue of ₹1,542.67 Cr grew 44.1% YoY and PAT of ₹239.77 Cr grew 28.3% YoY — both well short of the consolidated growth rates. The divergence traces to the "Others" segment (₹144.14 Cr this quarter, nil in the year-ago quarter), which reflects Himadri Integrated Minerals and Resources (consolidated from February 2026) and Ardent Impex Fzco, Dubai (from June 2026) — businesses with no footprint in the September-2025 base, so part of the headline consolidated growth is a consolidation effect rather than organic expansion. Street coverage remains thin, as flagged pre-result (effectively one analyst on record, Hold rating, targets split ₹480–720), so there is no independent quarterly consensus to check against beyond that FY27 full-year estimate (+34.8% revenue, +23.8% EPS, per Trendlyne) — this quarter's growth pace is broadly consistent with that trajectory. Management issued no press release alongside this filing (none available in our records), so there is no fresh management framing to reconcile against the numbers this quarter. Against the FY28 targets set out on the last call (₹1,100 Cr PAT, ₹2,000 Cr self-funded capex over FY27-28, ₹3,000 Cr LFP cathode revenue potential, Birla Tyres EBITDA-positive in FY27), H1 FY27 consolidated PAT stands at ₹459.75 Cr and segment capex continues (₹173–215 Cr spent on property/plant in H1 per the cash-flow statement) — directionally on track but still shy of the run-rate needed to hit ₹1,100 Cr by FY28, so the targets stay "on-plan" rather than confirmed. In-quarter corporate actions — the board's approval of the DBRL tyre-business demerger into HSCL (Sept 21, 2026, scheme filed with exchanges), a ₹150 Cr commercial paper raised and repaid within the quarter, and a 34% stake sale in a step-down subsidiary — did not flow through this P&L in a material way but mark continued portfolio and balance-sheet activity around the capacity build-out.

16 Oct 2026, 06:30 pm

Corporate Events

Board MeetingHSCL
2026
7Nov

Board Meeting

The Board of Directors considered and approved the issuance …

BSE Filing ↗
Board MeetingHSCL
2026
16Oct

Board Meeting

The Board of Directors will consider and approve the Un-Audi…

BSE Filing ↗
Board MeetingHSCL
2026
21Sep

Board Meeting

The Board of Directors will consider and approve the propose…

BSE Filing ↗
Board MeetingHSCL
2026
18Sep

Board Meeting

The Board of Directors considered and approved the alteratio…

BSE Filing ↗
Board MeetingHSCL
2026
15Jul

Board Meeting

A meeting of the Board of Directors will be held on 15 July …

BSE Filing ↗
Board MeetingHSCL
2026
6Jul

Board Meeting

The Nomination and Remuneration Committee of the Company met…

BSE Filing ↗
Board MeetingHSCL
2026
11Jun

Board Meeting

The 38th Annual General Meeting will be held to consider and…

BSE Filing ↗
DividendHSCL
2025
23May

₹0.6 / share

BSE Filing ↗
Board MeetingHSCL
2024
16Oct

Board Meeting

Consider and approve the Un-audited Financial Results (Stand…

BSE Filing ↗
Board MeetingHSCL
2024
16Jul

Board Meeting

Consider and approve Un-audited Standalone and Consolidated …

BSE Filing ↗
Board MeetingHSCL
2024
25Apr

Board Meeting

Approval and take on record of Audited Standalone and Consol…

BSE Filing ↗
Board MeetingHSCL
2024
20Mar

Board Meeting

Consideration and approval of notice for issuance of equity …

BSE Filing ↗
Board MeetingHSCL
2024
16Jan

Board Meeting

Consider and approve Notice and Un-audited Financial Results

BSE Filing ↗
Board MeetingHSCL
2023
17Oct

Board Meeting

Consider and approve Un-audited Standalone and Consolidated …

BSE Filing ↗